Skip to content
June 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Survivorship and Post-Treatment
  • A Decade of Hope: Carrying Forward the Legacy of Rochelle Shoretz and Sharsheret
  • Survivorship and Post-Treatment

A Decade of Hope: Carrying Forward the Legacy of Rochelle Shoretz and Sharsheret

Reynand Wu June 17, 2026 7 minutes read
a-decade-of-hope-carrying-forward-the-legacy-of-rochelle-shoretz-and-sharsheret

By Editorial Staff
December 01, 2025

In the landscape of modern patient advocacy, few organizations have managed to bridge the gap between clinical support and emotional resonance as effectively as Sharsheret. As the organization marks a decade since the passing of its founder, Rochelle Shoretz, her sons, Shlomo and Dovid Mirsky, have issued a poignant call to action. Their appeal serves not only as a tribute to a pioneering mother but as a stark reminder of the enduring necessity of specialized support for Jewish women and families facing breast and ovarian cancer.


The Genesis of an International Movement

The story of Sharsheret is one of necessity born from isolation. In 2001, when Rochelle Shoretz received her initial breast cancer diagnosis, the cultural climate surrounding the disease was vastly different. Cancer was largely treated as a private, often taboo, subject—a reality that exacerbated the loneliness of young mothers navigating the complexities of parenting, professional life, and religious observance while battling a life-threatening illness.

Shoretz, then a young mother herself, found herself searching for a peer who could navigate the intersection of faith, motherhood, and survivorship. This search led her to Lauryn Weiser, another young Jewish mother. The bond formed between these two women served as the blueprint for what would become Sharsheret (Hebrew for "chain"). Shoretz recognized that the informal, compassionate connection she had found with Weiser was a resource that thousands of other women lacked. What began as five women gathered around a dining room table in 2001 has, in the intervening years, blossomed into a global non-profit infrastructure.


Chronology: From Private Struggle to Public Pillar

2001: The Founding

Rochelle Shoretz establishes Sharsheret to provide psychosocial support to Jewish women facing breast cancer. The organization focuses on the "peer-to-peer" model, connecting newly diagnosed women with survivors who share similar backgrounds and experiences.

2001–2015: Scaling the Impact

Under Shoretz’s leadership, Sharsheret expands its services to include genetic counseling, financial assistance, and the "Busy Box" program—a resource designed to help children cope with a parent’s diagnosis. Shoretz’s personal journey remains the heartbeat of the organization, even as it professionalizes its clinical offerings.

2015: The Loss of a Visionary

In 2015, the community mourned the passing of Rochelle Shoretz. Her death left a void in the leadership of the organization, yet her foundational philosophy remained intact. The transition period proved that the organization’s mission had successfully transcended its founder’s individual presence.

2015–2025: A Decade of Growth

The ten years following Shoretz’s passing have seen the organization achieve record-breaking metrics. Today, Sharsheret assists more than 275,000 individuals annually, providing a comprehensive safety net that includes medical navigation, mental health support, and education regarding hereditary cancer risks.

Help Us Carry Forward Our Mother’s Legacy: Support Sharsheret This Year-End

Supporting Data: The Scope of the Crisis

The necessity for an organization like Sharsheret is underscored by the evolving understanding of cancer risks within the Jewish community. Ashkenazi Jewish women, for instance, carry a significantly higher risk of BRCA1 and BRCA2 gene mutations compared to the general population. This genetic reality makes organizations like Sharsheret critical not just for those currently battling cancer, but for those engaged in preventative care and genetic risk assessment.

Beyond the genetic data, the psychosocial impact of a cancer diagnosis on a family unit is profound. Research consistently shows that children of cancer patients are at higher risk for anxiety and developmental setbacks. Sharsheret’s specific focus on family-centered support—including the Busy Box program—addresses these "silent" victims of the disease, ensuring that the next generation is not left to process the trauma of a parent’s illness in isolation.

The organization’s current reach of 275,000 individuals served annually reflects a transition from a grassroots support group to a sophisticated healthcare partner. By integrating clinical, genetic, and emotional support, Sharsheret has effectively reduced the "time-to-care" for patients, helping them navigate a complex healthcare system that can often feel overwhelming during a crisis.


Official Responses and Reflective Insights

In a recent statement, Shlomo and Dovid Mirsky highlighted the duality of their experience: the personal loss of a mother and the public witnessing of her legacy.

"We were only 3 and 5 at the time when our mother was diagnosed," the Mirskys wrote in their year-end appeal. "As young children, receiving Sharsheret’s Busy Box helped distract us from the difficult realities of Mom’s cancer treatments. It is hard to believe it has been 10 years since Mom’s passing. She has missed so many milestones—from graduations to grandchildren—but we see her influence every day in the thousands of lives touched by this organization."

The brothers emphasize that their mother’s legacy is not merely in the name "Sharsheret," but in the tangible reduction of suffering for others. Their call for year-end donations is framed as an investment in the stability of the Jewish community. "What started as five women around our dining room table has turned into an international movement," they noted. "We know that thanks to your generosity, Mom is looking down with pride as we build a healthier and brighter future for the next generation."


Implications: The Road Ahead

As Sharsheret moves into its next decade, the implications of its work are twofold:

1. The Normalization of Patient Advocacy

Sharsheret has played a pivotal role in shifting the cultural narrative around cancer. By moving the conversation from the shadows into the light, they have empowered thousands of women to prioritize their health. The organization’s ability to remain culturally sensitive while maintaining high medical standards serves as a model for other faith-based health initiatives.

Help Us Carry Forward Our Mother’s Legacy: Support Sharsheret This Year-End

2. Sustaining the Operational Engine

The primary challenge for any non-profit that has grown as rapidly as Sharsheret is sustainability. The "year-end push" is not merely a fundraising tactic; it is the lifeblood of the organization. Because Sharsheret provides many of its services at no cost to the patients—including medical navigation and mental health support—the reliance on philanthropic contributions is absolute.

For the donor, the organization offers a high degree of transparency. The impact of a single donation can be traced directly to services that provide immediate, tangible relief to a family in crisis. Whether it is a mother receiving a wig, a child receiving a Busy Box, or a family navigating the complexities of genetic testing, the return on investment is measured in improved patient outcomes and reduced psychosocial distress.


Conclusion: A Call for Continuity

The tenth anniversary of Rochelle Shoretz’s passing is a milestone that demands reflection. It is a testament to the fact that while an individual’s life may have a finite timeline, a vision, when properly nurtured by a community, can become timeless.

As the year comes to a close, the Mirsky brothers’ appeal is clear: the chain of support that Shoretz forged must remain unbroken. By supporting Sharsheret this year, donors are not just contributing to a budget; they are participating in a multi-generational effort to ensure that no Jewish family has to face the terror of a cancer diagnosis alone.

For those wishing to contribute to this legacy, the organization has simplified the process through their online portal at link.Sharsheret.org/EOY. In doing so, they are helping to ensure that the work started at a small dining room table continues to reach those in need for decades to come.

As the community prepares for the upcoming season of light, the work of Sharsheret serves as a beacon for those navigating their own darkest chapters. Rochelle Shoretz may have been taken too soon, but through the hundreds of thousands of lives impacted by her organization, her spirit remains inextricably linked to the survival and resilience of the Jewish family.

About the Author

Reynand Wu

Author

View All Posts

Post navigation

Previous: From the Court to the Clinic: The Intersectional Power of Community and Early Detection in Breast Cancer Survival
Next: Regulatory Crossroads: FDA Skepticism Clouds Future of Moderna’s mRNA Flu Vaccine

Related Stories

honoring-the-journey-the-ultimate-guide-to-supporting-breast-cancer-survivors-and-thrivers
  • Survivorship and Post-Treatment

Honoring the Journey: The Ultimate Guide to Supporting Breast Cancer Survivors and Thrivers

Rifan Muazin June 17, 2026
small-hands-big-hearts-navigating-a-cancer-diagnosis-as-a-family-unit
  • Survivorship and Post-Treatment

Small Hands, Big Hearts: Navigating a Cancer Diagnosis as a Family Unit

Nana Wu June 16, 2026
beyond-the-diagnosis-navigating-the-complexities-of-breast-cancer-recurrence
  • Survivorship and Post-Treatment

Beyond the Diagnosis: Navigating the Complexities of Breast Cancer Recurrence

Nila Kartika Wati June 16, 2026

Recent Posts

  • Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data
  • Global Resilience and Regulatory Legacy: A Comprehensive Review of COVID-19 Data and Policy Tracking
  • Waking Up with Ease: The 9-Minute Morning Yoga Sequence Designed to Dissolve Daily Tension
  • Cambridge Breakthrough Achieves Unprecedented 100% Survival Rate in Aggressive Inherited Breast Cancers
  • Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

clinical-uncertainty-clouds-edgewise-therapeutics-latest-heart-drug-data
  • Chemotherapy and Targeted Therapy

Clinical Uncertainty Clouds Edgewise Therapeutics’ Latest Heart Drug Data

Raul Delapena Setiawan June 17, 2026
global-resilience-and-regulatory-legacy-a-comprehensive-review-of-covid-19-data-and-policy-tracking
  • Breast Cancer Legislation and Policy

Global Resilience and Regulatory Legacy: A Comprehensive Review of COVID-19 Data and Policy Tracking

Nana Wu June 17, 2026
waking-up-with-ease-the-9-minute-morning-yoga-sequence-designed-to-dissolve-daily-tension
  • Integrative Oncology and Holistic Care

Waking Up with Ease: The 9-Minute Morning Yoga Sequence Designed to Dissolve Daily Tension

Reynand Wu June 17, 2026
cambridge-breakthrough-achieves-unprecedented-100-survival-rate-in-aggressive-inherited-breast-cancers
  • Medical Research and Clinical Trials

Cambridge Breakthrough Achieves Unprecedented 100% Survival Rate in Aggressive Inherited Breast Cancers

Rifan Muazin June 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.